Prognostic factors in transformed mycosis fungoides: A retrospective analysis of 100 cases

203Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Large cell transformation (LCT) in mycosis fungoides (MF) is generally associated with an aggressive clinical course and poor survival, requiring aggressive therapeutic approach. However, a proportion of cases may follow an indolent clinical course. To identify prognostic factors,weanalyzed the prognostic relevance of clinical, histologic, and immunophenotypical features in a large cohort of transformed MF patients, including 75 patients with only skin lesions, 19 patients with LCT in skin and lymph nodes, and 6 patients with LCT in lymph nodes only. Multivariate analysis of the total group showed that CD30 negativity, folliculotropic MF, extent of skin lesions and extracutaneous transformation were associated with reduced disease-specific survival (DSS) and, except for CD30 negativity and folliculotropic MF, also overall survival. In a multivariate analysis of 75 patients with only skin lesions at the time of LCT, CD30 negativity, folliculotropic MF and extent of skin lesions were independent parameters for both DSS andoverall survival. Using the most discriminating parameters as a prognostic index, in both study groups differences in DSS between patients with 0-1 unfavorable prognostic factor(s) and ≥ 2 unfavorable prognostic factors were statistically significant (P < .001). This prognostic index may be helpful in predicting prognosis and selecting the most appropriate treatment in patients with transformed MF. © 2012 by The American Society of Hematology.

References Powered by Scopus

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

1259Citations
N/AReaders
Get full text

Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: Validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal

707Citations
N/AReaders
Get full text

Transformation of mycosis fungoides/Sezary syndrome: Clinical characteristics and prognosis

301Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model

336Citations
N/AReaders
Get full text

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): Part I. Diagnosis: Clinical and histopathologic features and new molecular and biologic markers

336Citations
N/AReaders
Get full text

Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sézary syndrome with variable CD30 expression level: A multi-institution collaborative project

247Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Benner, M. F., Jansen, P. M., Vermeer, M. H., & Willemze, R. (2012). Prognostic factors in transformed mycosis fungoides: A retrospective analysis of 100 cases. Blood, 119(7), 1643–1649. https://doi.org/10.1182/blood-2011-08-376319

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 50

68%

Researcher 15

20%

Professor / Associate Prof. 8

11%

Lecturer / Post doc 1

1%

Readers' Discipline

Tooltip

Medicine and Dentistry 61

76%

Biochemistry, Genetics and Molecular Bi... 10

13%

Psychology 5

6%

Nursing and Health Professions 4

5%

Save time finding and organizing research with Mendeley

Sign up for free